SSY GROUP (02005.HK) Secures NMPA Registration for Calcium Chloride Bulk Drug

Bulletin Express03-19

SSY Group Limited announced that its Calcium Chloride product has received registration approval from the National Medical Products Administration of China, officially qualifying it as a bulk drug for market-ready preparations.

Calcium Chloride is used as an additive in intravenous injections for treating calcium deficiency, tetany, vitamin D deficiency and allergic disorders, and is further applied in emergency interventions for magnesium or fluoride poisoning and certain cardiac dysfunctions associated with hyperkalemia, hypocalcemia or calcium-channel blockade.

The board noted that the approval marks a product-development milestone and keeps shareholders and potential investors informed of the Group’s latest business progress. The voluntary disclosure was signed by Executive Director and Company Secretary Chow Hing Yeung on 19 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192689040?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192689040","market":"hk","top_or_hot":-1,"title":"SSY GROUP (02005.HK) Secures NMPA Registration for Calcium Chloride Bulk Drug","media":"Bulletin Express","content":"<p>SSY Group Limited announced that its Calcium Chloride product has received registration approval from the National Medical Products Administration of China, officially qualifying it as a bulk drug for market-ready preparations.</p>\n<p>Calcium Chloride is used as an additive in intravenous injections for treating calcium deficiency, tetany, vitamin D deficiency and allergic disorders, and is further applied in emergency interventions for magnesium or fluoride poisoning and certain cardiac dysfunctions associated with hyperkalemia, hypocalcemia or calcium-channel blockade.</p>\n<p>The board noted that the approval marks a product-development milestone and keeps shareholders and potential investors informed of the Group’s latest business progress. The voluntary disclosure was signed by Executive Director and Company Secretary Chow Hing Yeung on 19 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SSY GROUP (02005.HK) Secures NMPA Registration for Calcium Chloride Bulk Drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSSY GROUP (02005.HK) Secures NMPA Registration for Calcium Chloride Bulk Drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-19 16:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SSY Group Limited announced that its Calcium Chloride product has received registration approval from the National Medical Products Administration of China, officially qualifying it as a bulk drug for market-ready preparations.</p>\n<p>Calcium Chloride is used as an additive in intravenous injections for treating calcium deficiency, tetany, vitamin D deficiency and allergic disorders, and is further applied in emergency interventions for magnesium or fluoride poisoning and certain cardiac dysfunctions associated with hyperkalemia, hypocalcemia or calcium-channel blockade.</p>\n<p>The board noted that the approval marks a product-development milestone and keeps shareholders and potential investors informed of the Group’s latest business progress. The voluntary disclosure was signed by Executive Director and Company Secretary Chow Hing Yeung on 19 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02005","symbol_name":"石四药集团","start_time":0,"source_url":"","article_id":"1192689040","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192689040","pubTimestamp":1773909778,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"SSY Group Limited announced that its Calcium Chloride product has received registration approval from the National Medical Products Administration of China, officially qualifying it as a bulk drug...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02005":"石四药集团"},"translate_title":"SSY集团(02005.HK)氯化钙原料药获NMPA注册","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02005":1},"content_text":"SSY Group Limited announced that its Calcium Chloride product has received registration approval from the National Medical Products Administration of China, officially qualifying it as a bulk drug for market-ready preparations.\nCalcium Chloride is used as an additive in intravenous injections for treating calcium deficiency, tetany, vitamin D deficiency and allergic disorders, and is further applied in emergency interventions for magnesium or fluoride poisoning and certain cardiac dysfunctions associated with hyperkalemia, hypocalcemia or calcium-channel blockade.\nThe board noted that the approval marks a product-development milestone and keeps shareholders and potential investors informed of the Group’s latest business progress. The voluntary disclosure was signed by Executive Director and Company Secretary Chow Hing Yeung on 19 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192689040","isCrawlerRequest":true}